Opening The Door For Cell Therapy In Solid Tumors

 
• By Daniel Chancellor
Immune response
Several groups shared research at ASCO for new CAR-T designs in well-defined subgroups of patients with solid tumors that have failed previous conventional therapies. • Source: Shutterstock

More from Clinical Trials

More from R&D